Breaking News Instant updates and real-time market news.

IMAX

Imax

$23.51

0.42 (1.82%)

04:55
05/15/19
05/15
04:55
05/15/19
04:55

Imax management to meet with B. Riley FBR

Meeting to be held in Charlotte, NC on May 15 hosted by B. Riley FBR.

  • 15

    May

  • 05

    Jun

  • 06

    Jun

IMAX Imax
$23.51

0.42 (1.82%)

02/25/19
ADAM
02/25/19
DOWNGRADE
Target $23
ADAM
Hold
Imax downgraded to Hold on weak box office trends at Canaccord
As reported previously, Canaccord analyst Aravinda Galappatthige downgraded Imax to Hold from Buy. The analyst downgraded the share ahead of Q4 results, citing weak box office trends, particularly in China. He believes the uncertainty around the China outlook and the less friendly slate of movies for 2019 will also be headwinds. Galappatthige lowered his price target to $23 from $33 on Imax shares.
02/25/19
02/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Imax (IMAX) downgraded to Hold from Buy Canaccord by analyst Aravinda Galappatthige, who cited weak box office trends, particularly in China. He believes the uncertainty around the China outlook and the less friendly slate of movies for 2019 will also be headwinds. 2. SQM (SQM) downgraded to Hold from Buy at Deutsche Bank by analyst Chris Terry, who said he is moving to the sidelines following the 9% share price increase over the past two weeks. He likes the fundamentals of the business but believes that the first half of the year "could still provide some moderate headwinds." 3. PayPal (PYPL) downgraded to Neutral from Buy at Buckingham. 4. Motif Bio (MTFB) downgraded to Neutral from Buy at H.C. Wainwright by analyst Raghuram Selvaraju, who said he is unsure whether the FDA would ever approve iclaprim, "regardless of what data Motif might be able to furnish." Further, he believes there is "considerable uncertainty regarding Motif's ability to fund such studies." 5. Allegion (ALLE) downgraded to In-Line from Outperform at Imperial Capital by analyst Jeff Kessler, who sees 7% potential upside following the company's Q4 results and 2019 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
MKMP
04/12/19
NO CHANGE
Target $28
MKMP
Buy
Imax price target raised to $28 from $27 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Imax to $28 and kept his Buy rating, saying the company's "refocused efforts toward its core business" are on track to produce "near double-digit global box office growth, expanded gross margin, and rising free cash flow generation" in 2019. The analyst also raises his FY19 EPS view by 2c to $1.11 going into the release of "Avengers: Endgame" title later this month and the start of the summer season.
04/30/19
BRRR
04/30/19
NO CHANGE
BRRR
Barrington says 'Endgame' highlights blockbuster strategy opportunity for IMAX
Barrington analyst James Goss reaffirmed an Outperform rating and $27 price target on IMAX following "Avengers: Endgame" having the biggest opening of all time both domestically and in key international markets this past weekend. Goss said the "hit driven element" in Imax's growth due to the company's focus on blockbuster films, and it shows, as management "raised its 2019 IMAX box office guidance to a low-double-digit percentage gain, which contrasts with much more modest expectations for the overall domestic box office, with which IMAX does not totally compare in film mix."

TODAY'S FREE FLY STORIES

RDS.A

Royal Dutch Shell

$55.71

-0.37 (-0.66%)

16:11
08/20/19
08/20
16:11
08/20/19
16:11
Initiation
Royal Dutch Shell initiated  »

Royal Dutch Shell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.45

-0.41 (-1.11%)

16:11
08/20/19
08/20
16:11
08/20/19
16:11
Initiation
BP initiated  »

BP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.98

0.12 (0.58%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Breaking Hot Stocks news story on Urban Outfitters »

Urban Outfitters down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.55

-0.24 (-0.75%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Earnings
Scansource sees Q1 non-GAAP EPS 70c-75c, consensus 35c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

URBN

Urban Outfitters

$20.97

0.11 (0.53%)

16:09
08/20/19
08/20
16:09
08/20/19
16:09
Hot Stocks
Urban Outfitters says total inventory increased by $64.4M as of July 31 »

As of July 31, total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.96

0.1 (0.48%)

16:08
08/20/19
08/20
16:08
08/20/19
16:08
Hot Stocks
Urban Outfitters reports Q2 comparable retail segment net sales down 3% »

Q2 comparable retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

URBN

Urban Outfitters

$20.92

0.06 (0.29%)

16:07
08/20/19
08/20
16:07
08/20/19
16:07
Earnings
Urban Outfitters reports Q2 EPS 61c, consensus 58c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

SCSC

Scansource

$31.85

0.06 (0.19%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Scansource reports Q4 non-GAAP EPS 71c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 19

    Sep

REI

Ring Energy

$1.66

-0.07 (-4.06%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Earnings
Ring Energy releases mid-Q3 operations update »

Ring Energy released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYBX

Synlogic

$3.45

-1.37 (-28.42%)

16:06
08/20/19
08/20
16:06
08/20/19
16:06
Downgrade
Synlogic rating change  »

Synlogic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$58.36

0.08 (0.14%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Earnings
Cree sees Q1 adjusted EPS (7c)-(3c), consensus 15c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

MOGO

Mogo Finance

$2.60

(0.00%)

16:03
08/20/19
08/20
16:03
08/20/19
16:03
Hot Stocks
Mogo Finance surpasses 900,000 member milestone »

Mogo announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$58.35

0.07 (0.12%)

16:01
08/20/19
08/20
16:01
08/20/19
16:01
Earnings
Cree reports Q4 adjusted EPS 11c, consensus 10c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

BCRX

BioCryst

$2.70

0.025 (0.94%)

16:00
08/20/19
08/20
16:00
08/20/19
16:00
Conference/Events
BioCryst management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

15:55
08/20/19
08/20
15:55
08/20/19
15:55
Conference/Events
Cantor Fitzgerald tech analyst to hold an analyst/industry conference call »

Technology & Business…

LZB

La-Z-Boy

$30.73

-1.14 (-3.58%)

15:42
08/20/19
08/20
15:42
08/20/19
15:42
Options
La Z Boy options imply 11.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

MAS

Masco

$39.07

0.26 (0.67%)

15:41
08/20/19
08/20
15:41
08/20/19
15:41
Periodicals
Bain, AIP said bidding on Masco cabinet unit, Bloomberg reports »

The unit is said to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALC

Alcon

$62.41

0.62 (1.00%)

15:34
08/20/19
08/20
15:34
08/20/19
15:34
Options
Alcon options imply 5.4% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

TSLA

Tesla

$225.57

-1.18 (-0.52%)

, WMT

Walmart

$112.40

-1.36 (-1.20%)

15:28
08/20/19
08/20
15:28
08/20/19
15:28
Periodicals
Breaking Periodicals news story on Tesla, Walmart »

Walmart sues Tesla over…

TSLA

Tesla

$225.57

-1.18 (-0.52%)

WMT

Walmart

$112.40

-1.36 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

VTGN

VistaGen Therapeutics

$0.62

(0.00%)

15:26
08/20/19
08/20
15:26
08/20/19
15:26
Hot Stocks
VistaGen not 'a one product' company, says CEO »

VistaGen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

JKHY

Jack Henry

$140.60

-0.91 (-0.64%)

15:19
08/20/19
08/20
15:19
08/20/19
15:19
Options
Jack Henry options imply 5.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 12

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/20/19
08/20
15:17
08/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/20/19
08/20
15:16
08/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTGN

VistaGen Therapeutics

$0.62

(0.00%)

15:11
08/20/19
08/20
15:11
08/20/19
15:11
Hot Stocks
VistaGen's Singh says partnerships in large markets outside U.S. make most sense »

VistaGen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SABR

Sabre

$23.74

-0.19 (-0.79%)

15:10
08/20/19
08/20
15:10
08/20/19
15:10
Hot Stocks
Sabre to challenge DOJ lawsuit seeking to block Farelogix acquisition »

Sabre Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.